Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications

Research output: Contribution to journalArticleResearchpeer review

Authors

Research Organisations

External Research Organisations

  • Istituto Nazionale Neurologico C Besta, Milan
  • Medical Research Council
View graph of relations

Details

Original languageEnglish
Pages (from-to)575-584
Number of pages10
JournalBioscience reports
Volume33
Issue number4
Publication statusPublished - 25 Jul 2013

Abstract

Hydrogen sulfide is a physiologically relevant signalling molecule. However, circulating levels of this highly biologically active substance have to be maintained within tightly controlled limits in order to avoid toxic side effects. In patients suffering from EE (ethylmalonic encephalopathy), a block in sulfide oxidation at the level of the SDO (sulfur dioxygenase) ETHE1 leads to severe dysfunctions in microcirculation and cellular energy metabolism. We used an Ethe1-deficient mouse model to investigate the effect of increased sulfide and persulfide concentrations on liver, kidney, muscle and brain proteomes. Major disturbances in post-translational protein modifications indicate that the mitochondrial sulfide oxidation pathway could have a crucial function during sulfide signalling most probably via the regulation of cysteine S-modifications. Our results confirm the involvement of sulfide in redox regulation and cytoskeleton dynamics. In addition, they suggest that sulfide signalling specifically regulates mitochondrial catabolism of FAs (fatty acids) and BCAAs (branched-chain amino acids). These findings are particularly relevant in the context of EE since they may explain major symptoms of the disease.

Keywords

    Branched-chain amino acid oxidation, Ethylmalonic encephalopathy, Hydrogen sulfide, Mitochondria, Redox regulation, Sulfur dioxygenase

ASJC Scopus subject areas

Cite this

Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications. / Hildebrandt, Tatjana M.; Di Meo, Ivano; Zeviani, Massimo et al.
In: Bioscience reports, Vol. 33, No. 4, 25.07.2013, p. 575-584.

Research output: Contribution to journalArticleResearchpeer review

Download
@article{ff3015d5e2954b6da6f75e8aa96a84eb,
title = "Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications",
abstract = "Hydrogen sulfide is a physiologically relevant signalling molecule. However, circulating levels of this highly biologically active substance have to be maintained within tightly controlled limits in order to avoid toxic side effects. In patients suffering from EE (ethylmalonic encephalopathy), a block in sulfide oxidation at the level of the SDO (sulfur dioxygenase) ETHE1 leads to severe dysfunctions in microcirculation and cellular energy metabolism. We used an Ethe1-deficient mouse model to investigate the effect of increased sulfide and persulfide concentrations on liver, kidney, muscle and brain proteomes. Major disturbances in post-translational protein modifications indicate that the mitochondrial sulfide oxidation pathway could have a crucial function during sulfide signalling most probably via the regulation of cysteine S-modifications. Our results confirm the involvement of sulfide in redox regulation and cytoskeleton dynamics. In addition, they suggest that sulfide signalling specifically regulates mitochondrial catabolism of FAs (fatty acids) and BCAAs (branched-chain amino acids). These findings are particularly relevant in the context of EE since they may explain major symptoms of the disease.",
keywords = "Branched-chain amino acid oxidation, Ethylmalonic encephalopathy, Hydrogen sulfide, Mitochondria, Redox regulation, Sulfur dioxygenase",
author = "Hildebrandt, {Tatjana M.} and {Di Meo}, Ivano and Massimo Zeviani and Carlo Viscomi and Braun, {Hans Peter}",
year = "2013",
month = jul,
day = "25",
doi = "10.1042/BSR20130051",
language = "English",
volume = "33",
pages = "575--584",
journal = "Bioscience reports",
issn = "0144-8463",
publisher = "Portland Press Ltd.",
number = "4",

}

Download

TY - JOUR

T1 - Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications

AU - Hildebrandt, Tatjana M.

AU - Di Meo, Ivano

AU - Zeviani, Massimo

AU - Viscomi, Carlo

AU - Braun, Hans Peter

PY - 2013/7/25

Y1 - 2013/7/25

N2 - Hydrogen sulfide is a physiologically relevant signalling molecule. However, circulating levels of this highly biologically active substance have to be maintained within tightly controlled limits in order to avoid toxic side effects. In patients suffering from EE (ethylmalonic encephalopathy), a block in sulfide oxidation at the level of the SDO (sulfur dioxygenase) ETHE1 leads to severe dysfunctions in microcirculation and cellular energy metabolism. We used an Ethe1-deficient mouse model to investigate the effect of increased sulfide and persulfide concentrations on liver, kidney, muscle and brain proteomes. Major disturbances in post-translational protein modifications indicate that the mitochondrial sulfide oxidation pathway could have a crucial function during sulfide signalling most probably via the regulation of cysteine S-modifications. Our results confirm the involvement of sulfide in redox regulation and cytoskeleton dynamics. In addition, they suggest that sulfide signalling specifically regulates mitochondrial catabolism of FAs (fatty acids) and BCAAs (branched-chain amino acids). These findings are particularly relevant in the context of EE since they may explain major symptoms of the disease.

AB - Hydrogen sulfide is a physiologically relevant signalling molecule. However, circulating levels of this highly biologically active substance have to be maintained within tightly controlled limits in order to avoid toxic side effects. In patients suffering from EE (ethylmalonic encephalopathy), a block in sulfide oxidation at the level of the SDO (sulfur dioxygenase) ETHE1 leads to severe dysfunctions in microcirculation and cellular energy metabolism. We used an Ethe1-deficient mouse model to investigate the effect of increased sulfide and persulfide concentrations on liver, kidney, muscle and brain proteomes. Major disturbances in post-translational protein modifications indicate that the mitochondrial sulfide oxidation pathway could have a crucial function during sulfide signalling most probably via the regulation of cysteine S-modifications. Our results confirm the involvement of sulfide in redox regulation and cytoskeleton dynamics. In addition, they suggest that sulfide signalling specifically regulates mitochondrial catabolism of FAs (fatty acids) and BCAAs (branched-chain amino acids). These findings are particularly relevant in the context of EE since they may explain major symptoms of the disease.

KW - Branched-chain amino acid oxidation

KW - Ethylmalonic encephalopathy

KW - Hydrogen sulfide

KW - Mitochondria

KW - Redox regulation

KW - Sulfur dioxygenase

UR - http://www.scopus.com/inward/record.url?scp=84881530220&partnerID=8YFLogxK

U2 - 10.1042/BSR20130051

DO - 10.1042/BSR20130051

M3 - Article

C2 - 23800285

AN - SCOPUS:84881530220

VL - 33

SP - 575

EP - 584

JO - Bioscience reports

JF - Bioscience reports

SN - 0144-8463

IS - 4

ER -

By the same author(s)